Tag: single-cell omics market

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Single-Cell Omics Market Expected To Grow In Terms Of Size?

The size of the single-cell omics market has seen significant expansions recently. The projections show an increase from $2.08 billion in 2024 to $2.39 billion in 2025, showcasing a compound annual growth rate (CAGR) of 14.9%. The previous growth in this specific market is connected to factors such as the advances in discovering cellular heterogeneity, the development of single-cell analysis tools, substantial progress in biomedical research, breakthroughs in immune system characterization, and the inception of precision medicine.

The size of the single-cell omics market is predicted to experience a swift expansion in the upcoming years, escalating to a figure of $4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. The surge throughout the forecast period is credited to factors such as its clinical application and diagnostics, pairing with multi-omics methodologies, usage in regenerative medicine, the process of drug creation and discovery, as well as cellular treatments and immune therapies. Anticipated trends within this duration encompass in vivo single-cell exploration, application of single-cell omics in the study of infectious diseases, microfluidics integrated with single-cell sorting, amalgamation of single-cell multi-omics, and geographical single-cell profiling.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Growth Drivers Are Shaping The Single-Cell Omics Market Outlook?

The increase in cancer cases is predicted to spur the expansion of the single-cell omics market. Cancer encompasses a range of diseases that can occur almost anywhere in the body when rogue cells grow recklessly, overstep their normal limits, and either metastasize to other organs or invade adjacent body parts. The detection of cancer biomarkers for diagnosis and prognosis prediction, as well as the identification of new therapeutic targets in pre-established clinical groups, greatly benefits from single-cell omics data. For example, the National Institutes of Health, a government agency based in the United States, stated in May 2024 that as of January 2022, nearly 18.1 million people in the United States were living as cancer survivors. This figure is projected to increase to 22.5 million by 2032. Consequently, the rising incidence of cancer is contributing to the growth of the single-cell omics market.

How Is The Global Single-Cell Omics Market Broken Down By Segment?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Likely To Redefine Growth Paths In The Single-Cell Omics Market?

One emerging trend that’s gaining traction in the single-cell omics market is product innovation. To maintain their market position, leading businesses in the single-cell omics sector are focusing on the creation of innovative products. Take for example Deepcell, an American software company specializing in single-cell dimensional morphology analysis, which in May 2023, introduced the REM-I Platform. This scalable single-cell imaging platform combines high-dimensional analysis and cell sorting, opening up new realms of exploration in various fields such as cancer biology, developmental biology, gene therapy, stem cell biology, and functional screening among others. Moreover, it provides insights into cell biology that were previously out of reach.

Who Are The Most Influential Companies In The Single-Cell Omics Market?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Single-Cell Omics Market Expected to Be in 2029?

The market size of single-cell omics has experienced a swift expansion in the past few years. It is projected to escalate from $2.08 billion in 2024 to $2.39 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.9%. The substantial growth during the historical period was driven by factors such as the discovery of cellular heterogeneity, the development of single-cell analysis tools, advancements in biomedical research, characterizing the immune system, and the emergence of precision medicine.

The market size for single-cell omics is projected to experience swift expansion in the coming years, ballooning to “$4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. This expansion during the forecast period can be linked to its clinical adoption and diagnostics, its integration with multi-omics approaches, its application in regenerative medicine, pharmaceutical development and discovery, cellular treatments and immunotherapies. Key trends forecasted in this period include single-cell in vivo studies, single-cell omics investigations related to infectious diseases, microfluidics and single-cell sorting, integration of single-cell multi-omics, and spatial profiling of single cells.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Are The Contributors To Demand In The Single-Cell Omics Market?

The mounting occurrence of cancer is projected to drive the ascent of the single-cell omics market in the foreseeable future. Cancer constitutes a range of diseases that can materialize in virtually any organ or tissue when deviant cells expand uncontrollably, breach their traditional boundaries, and spread to other organs or encroach upon surrounding body parts. The practice of discerning biomarkers for diagnosing cancer, forecasting prognosis, and unveiling new therapeutic objectives in pre-established clinical groups has significantly capitalized on single-cell omics data. For example, in May 2024, the National Institutes of Health, a governmental body in the US, reported that as of January 2022, nearly 18.1 million Americans were living as survivors of cancer. This figure is predicted to escalate to 22.5 million by 2032. As such, the escalating frequency of cancer is promoting the advancement of the single-cell omics market.

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Long-Term Trends Are Likely To Affect The Single-Cell Omics Market?

The rising trend of product innovation is making a significant impact in the single-cell omics market. Major players in this market are introducing innovative products to maintain their market dominance. An illustration of this is the May 2023 launch of the REM-I Platform by Deepcell, a US-based firm that provides software for single-cell dimensional morphology analysis. This scalable single-cell imaging, high-dimensional analysis, and cell sorting platform offer previously unachievable insights into cell biology. The REM-I Platform is expected to inspire new methods of discovery in multiple areas, such as cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, among others, by consolidating single-cell imaging, sorting, and high-dimensional analysis.

Who Are The Top-Ranked Companies In The Single-Cell Omics Market Today?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How Is Single-Cell Omics Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Single-Cell Omics Market?

In recent times, the market size for single-cell omics has experienced a significant escalation. The expectations are that it will escalate from $2.08 billion in 2024 to $2.39 billion in 2025, portraying a compound annual growth rate (CAGR) of 14.9%. The profound growth observed in the historic period could be credited to factors such as the discovery of cellular heterogeneity, the advent of tools for single cell analysis, advancements in biomedical research, characterization of the immune system, and the burgeoning field of precision medicine.

The market size of single-cell omics is projected to witness rapid expansion in the approaching years, expanding to $4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. The surge during the forecast period can be ascribed to its clinical use and diagnosis, combined with multi-omics strategies, its implementation in regenerative medication, drug discovery and development, cell treatments, and immune therapies. Prominent trends during the forecast time frame encompass in vivo single-cell investigations, single-cell omics in research for infectious disease, microfluidics coupled with single-cell sorting, the integration of single-cell multi-omics, and spatial single-cell profiling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Factor Is Shaping The Future Of The Single-Cell Omics Market?

The increase in cancer cases is projected to drive the expansion of the single-cell omics market. Cancer, a class of diseases that can occur in almost any organ or tissue when rogue cells multiply beyond control, breach their normal limits, and either spread to other organs or infiltrate adjacent body parts, has been a significant factor. The role of single-cell omics data has been instrumental in identifying cancer biomarkers, prognosis predictions, and the exploration of new therapeutic targets within set clinical cohorts. For illustration, the National Institutes of Health, a United States government agency, disclosed in May 2024 that as of January 2022, the United States had about 18.1 million people living as cancer survivors. This estimate is predicted to surge to 22.5 million by 2032. Therefore, the escalating incidence of cancer is pushing the growth of the single-cell omics market.

What Is The Segment-Wise Breakdown Of The Single-Cell Omics Market?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Redefining The Future Landscape Of The Single-Cell Omics Industry?

The incorporation of Artificial Intelligence (AI) within the drug discovery sector is becoming a prominent trend in the small-molecule drug discovery market. Major firms within this market are using AI as a tool to expedite their drug discovery processes and maintain a competitive edge. In May 2023, an illustration of this trend was seen when Google Cloud, Google’s cloud computing component based in the US, introduced the Target and Lead Identification Suite along with the Multiomics Suite. These initiatives aim to streamline drug discovery. The Multiomics Suite aids in the swift identification and analysis of genetic information, helping businesses to develop precision medicines. Meanwhile, the Target and Lead Identification Suite assists researchers to comprehend the function of amino acids and predict protein structures.

Which Companies Hold The Largest Market Share In The Single-Cell Omics Sector?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How Does Regional Performance Compare Across The Single-Cell Omics Industry?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Forecasted Growth Rate and Market Size of the Single-Cell Omics Market?

In recent times, the market size for single-cell omics has experienced a significant escalation. The expectations are that it will escalate from $2.08 billion in 2024 to $2.39 billion in 2025, portraying a compound annual growth rate (CAGR) of 14.9%. The profound growth observed in the historic period could be credited to factors such as the discovery of cellular heterogeneity, the advent of tools for single cell analysis, advancements in biomedical research, characterization of the immune system, and the burgeoning field of precision medicine.

The market size of single-cell omics is projected to witness rapid expansion in the approaching years, expanding to $4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. The surge during the forecast period can be ascribed to its clinical use and diagnosis, combined with multi-omics strategies, its implementation in regenerative medication, drug discovery and development, cell treatments, and immune therapies. Prominent trends during the forecast time frame encompass in vivo single-cell investigations, single-cell omics in research for infectious disease, microfluidics coupled with single-cell sorting, the integration of single-cell multi-omics, and spatial single-cell profiling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Factor Is Shaping The Future Of The Single-Cell Omics Market?

The increase in cancer cases is projected to drive the expansion of the single-cell omics market. Cancer, a class of diseases that can occur in almost any organ or tissue when rogue cells multiply beyond control, breach their normal limits, and either spread to other organs or infiltrate adjacent body parts, has been a significant factor. The role of single-cell omics data has been instrumental in identifying cancer biomarkers, prognosis predictions, and the exploration of new therapeutic targets within set clinical cohorts. For illustration, the National Institutes of Health, a United States government agency, disclosed in May 2024 that as of January 2022, the United States had about 18.1 million people living as cancer survivors. This estimate is predicted to surge to 22.5 million by 2032. Therefore, the escalating incidence of cancer is pushing the growth of the single-cell omics market.

What Is The Segment-Wise Breakdown Of The Single-Cell Omics Market?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Which Trends Are Redefining The Future Landscape Of The Single-Cell Omics Industry?

The incorporation of Artificial Intelligence (AI) within the drug discovery sector is becoming a prominent trend in the small-molecule drug discovery market. Major firms within this market are using AI as a tool to expedite their drug discovery processes and maintain a competitive edge. In May 2023, an illustration of this trend was seen when Google Cloud, Google’s cloud computing component based in the US, introduced the Target and Lead Identification Suite along with the Multiomics Suite. These initiatives aim to streamline drug discovery. The Multiomics Suite aids in the swift identification and analysis of genetic information, helping businesses to develop precision medicines. Meanwhile, the Target and Lead Identification Suite assists researchers to comprehend the function of amino acids and predict protein structures.

Which Companies Hold The Largest Market Share In The Single-Cell Omics Sector?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How Does Regional Performance Compare Across The Single-Cell Omics Industry?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Single-Cell Omics Market Grown from 2024 to 2025?

Over the past few years, the single-cell omics market size has experienced rapid expansion. It is projected to increase from $2.08 billion in 2024 to $2.41 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.9%. The significant growth during the historic period can be attributed to factors such as the discovery of cellular heterogeneity, the development of single-cell analysis tools, advancements in biomedical research, characterisation of the immune system, and the proliferation of precision medicine.

What Growth Rate Is Anticipated for the Single-Cell Omics Market in the Coming Years?

The size of the single-cell omics market is projected to experience swift expansion in the coming years, reaching a market value of $4.52 billion in 2029 with a CAGR of 17.0%. The surge during the forecast period can be ascribed to its adoption in clinical and diagnostic settings, combination with multi-omics techniques, utilization in regenerative medicine, application in pharmaceutical innovation and discovery, cell therapies, and immunotherapies. Key trends noted during the forecast period consist of in vivo single-cell studies, the use of single-cell omics in investigating infectious diseases, microfluidics in single-cell separation, integration of single-cell multi-omics, and spatial single-cell profiling.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Who Are the Leading Companies in the Single-Cell Omics Market?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

What Are the Key Drivers of the Single-Cell Omics Market?

The anticipated escalation in cancer prevalence is predicted to fuel the expansion of the single-cell omics market. Cancer encompasses a range of diseases that can originate in virtually any organ or tissue when cells deviate and grow uncontrollably, overreaching their normal limits, and either metastasize to other organs or infiltrate nearby body structures. The utilization of single-cell omics data has been instrumental in the detection of biomarkers for cancer, forecasting prognosis, and uncovering new treatment targets in pre-established clinical cohorts. For example, the National Institutes of Health, a government agency based in the US, stated in May 2024 that around 18.1 million US residents were living as cancer survivors as of January 2022. This figure is projected to ascend to 22.5 million by 2032. Consequently, the increasing prevalence of cancer is steering the growth of the single-cell omics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

What Are the Key Market Segments in the Single-Cell Omics Industry?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Are the Latest Trends in the Single-Cell Omics Market?

The trend of product innovation is rapidly growing within the single-cell omics market. The primary companies within this market are developing trailblazing products in order to secure and maintain their market standing. An example of this is Deepcell, a United States-based software company focusing on single-cell dimensional morphology analysis. In May 2023, Deepcell launched the REM-I Platform, a versatile single-cell imaging, in-depth analysis, and cell sorting platform. This groundbreaking product offers novel insights into cell biology that were previously unobtainable. The REM-I Platform is fostering fresh avenues for discoveries in a variety of fields such as cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening among others. This is achieved by amalgamating single-cell imaging, sorting, and extensive dimensional analysis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

What Are the Key Regional Markets in the Single-Cell Omics Industry?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

This Report Delivers Insight On:

1. How big is the single-cell omics market, and how is it changing globally?

2. Who are the major companies in the single-cell omics market, and how are they performing?

3. What are the key opportunities and risks in the single-cell omics market right now?

4. Which products or customer segments are growing the most in the single-cell omics market?

5. What factors are helping or slowing down the growth of the single-cell omics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theSingle-Cell Omics Market?

The increase in cancer incidents is predicted to boost the expansion of the single-cell omics market. Cancer represents a group of diseases that can occur in almost any organ or tissue when rogue cells multiply excessively, cross their normal borders, and either migrate to other organs or infiltrate surrounding body parts. The identification of cancer biomarkers for diagnosis, prognosis estimation, and the unearthing of new treatment targets within predefined clinical groups has greatly leveraged single-cell omics data. For example, as reported by the National Institutes of Health, a US government agency, in May 2024, around 18.1 million people in the U.S. were identified as cancer survivors in January 2022. This figure is projected to climb to 22.5 million by 2032. As a result, the growing frequency of cancer is stimulating the rise of the single-cell omics market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

#What Long-Term Growth Rate is Expected for theSingle-Cell Omics Market Between 2025 and 2034?

The market size of single-cell omics has experienced rapid expansion in the last few years. It is expected to increase from $2.08 billion in 2024 to reach $2.41 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 15.9%. The unprecedented growth during the historical time frame could be credited to the unearthing of cellular heterogeneity, the development of single-cell analysis instruments, advancements in biomedical research, in-depth study of the immune system, and the upswing in precision medicine.

The market size of single-cell omics is predicted to experience a significant expansion in the coming years, rising to a value of $4.52 billion in 2029 with a compound annual growth rate (CAGR) of 17.0%. This expected growth during the forecast period is due to factors such as its clinical implementation and diagnostic uses, its integration with multiple omics techniques, and its application in areas like regenerative medicine, drug innovation and discovery, and cellular and immune therapies. Key trends anticipated during this forecast period involve in vivo studies of single cells, single-cell omics applications in studying infectious diseases, the use of microfluidics and cell sorting at the single cell level, the integration of multi-omics at the single cell level, and profiling of single cells in spatial context.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

What Key Market Trends and Innovations Are Shaping the Future of theSingle-Cell Omics Industry?

In the single-cell omics market, a leading trend is product innovation. To maintain their market position, predominant companies in this market are focusing on the production of novel products. For example, in May 2023, Deepcell – a US-based software provider specializing in single-cell dimensional morphology analysis – unveiled the REM-I Platform. This new platform, capable of scalable single-cell imaging, high-dimensional analysis, and effective cell sorting, offers unprecedented insight into the complex world of cell biology. With its ability to combine single-cell imaging, sorting, and high-dimensional analysis, the REM-I Platform is expected to open new avenues for discovery in a range of areas, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening among others.

Which Companies Are Leading the Charge in Expanding theSingle-Cell Omics Market Growth?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How is the Global Single-Cell Omics Market Segemented?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

Which Geographics are Influencing the Growth of the Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Single-Cell Omics Maret 2025, By The Business Research Company:

Cell and Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Analyzing the Growth Rate of the Single-Cell Omics Market: What’s the Expected CAGR for the Next Decade?

The single-cell omics market has seen notable expansion in recent years. It is forecasted to grow from $2.08 billion in 2024 to $2.41 billion in 2025, with a CAGR of 15.9%. Factors contributing to historical growth include the discovery of cellular heterogeneity, advancements in single-cell analysis tools, progress in biomedical research, characterization of the immune system, and the increasing adoption of precision medicine.

The single-cell omics market is projected to witness strong growth, reaching $4.52 billion by 2029 at a CAGR of 17.0%. Factors contributing to this expansion include increased clinical adoption, integration with multi-omics approaches, applications in regenerative medicine, drug discovery, and advancements in cellular therapies and immunotherapies. Major trends include in vivo single-cell studies, applications in infectious disease research, advancements in microfluidics and cell sorting, integration of multi-omics techniques, and progress in spatial single-cell profiling.

What Strategic Factors Are Influencing the Accelerated Growth of the Market?

The increasing prevalence of cancer is projected to drive the growth of the single-cell omics market going forward. Cancer can develop in nearly any organ or tissue in the body when abnormal cells proliferate uncontrollably, cross normal boundaries, and invade other organs or nearby tissues. Single-cell omics data has been significantly utilized for identifying biomarkers for cancer diagnosis, prognosis prediction, and discovering new therapeutic targets in defined clinical cohorts. For instance, in May 2024, the National Institutes of Health, a US-based government agency, indicated that approximately 18.1 million people in the United States were living as cancer survivors as of January 2022. This figure is expected to rise to 22.5 million by 2032. Therefore, the increasing prevalence of cancer is driving the growth of the single-cell omics market.

Request Your Free Single-Cell Omics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Are the Leading Organizations Impacting the Single-Cell Omics Market’s Growth?

Major companies operating in the single-cell omics market include:

• Danaher Corporation

• Merck KGaA

• Becton Dickinson and Company

• GE HealthCare Technologies Inc.

• Thermo Fischer Scientific Inc.

What Are the Most Prominent Trends Driving Change in the Single-Cell Omics Market?

Product innovation is a dominant trend in the single-cell omics market, with leading companies developing novel solutions to maintain their position. For instance, in May 2023, Deepcell, a US-based software company specializing in single-cell morphological analysis, introduced the REM-I Platform. This scalable platform combines single-cell imaging, high-dimensional analysis, and cell sorting, delivering unprecedented insights into cancer biology, developmental biology, stem cell research, gene therapy, and functional screening.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Single-Cell Omics Market?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Regions Are Leading the Charge in the Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Single-Cell Omics Market Categorized and Defined in the Industry?

Single-cell omics refers to the profile of single cells taken from heterogeneous populations of cells in various cellular stages, allowing for the study and dissection of both healthy development and disease processes at the single-cell level. Single-cell omics are used for the molecular analysis of cellular heterogeneity, cell type identification, illness research, and the creation of therapeutics.

Browse Through More Similar Reports By The Business Research Company:

Cell and Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: